JP2006056808A - Anti-inflammatory skin care formulation containing extract of root of luffa - Google Patents
Anti-inflammatory skin care formulation containing extract of root of luffa Download PDFInfo
- Publication number
- JP2006056808A JP2006056808A JP2004238725A JP2004238725A JP2006056808A JP 2006056808 A JP2006056808 A JP 2006056808A JP 2004238725 A JP2004238725 A JP 2004238725A JP 2004238725 A JP2004238725 A JP 2004238725A JP 2006056808 A JP2006056808 A JP 2006056808A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- loofah
- inflammatory skin
- root
- external preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000284 extract Substances 0.000 title claims abstract description 46
- 230000003110 anti-inflammatory effect Effects 0.000 title claims abstract description 29
- 239000000203 mixture Substances 0.000 title abstract description 22
- 238000009472 formulation Methods 0.000 title abstract description 21
- 235000003956 Luffa Nutrition 0.000 title abstract 4
- 244000050983 Luffa operculata Species 0.000 title 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 65
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000002904 solvent Substances 0.000 claims abstract description 12
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims abstract description 10
- 235000009814 Luffa aegyptiaca Nutrition 0.000 claims description 42
- 238000002360 preparation method Methods 0.000 claims description 25
- 239000002537 cosmetic Substances 0.000 claims description 15
- 206010061218 Inflammation Diseases 0.000 claims description 8
- 230000004054 inflammatory process Effects 0.000 claims description 8
- 244000280244 Luffa acutangula Species 0.000 claims 2
- 238000000605 extraction Methods 0.000 abstract description 13
- 206010015150 Erythema Diseases 0.000 abstract description 9
- 231100000321 erythema Toxicity 0.000 abstract description 7
- 201000004624 Dermatitis Diseases 0.000 abstract description 4
- 241000219138 Luffa Species 0.000 abstract 3
- 244000302544 Luffa aegyptiaca Species 0.000 description 40
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 30
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 18
- -1 lipsticks Substances 0.000 description 18
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 16
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- 239000008213 purified water Substances 0.000 description 12
- 239000006071 cream Substances 0.000 description 10
- 239000003205 fragrance Substances 0.000 description 10
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 9
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 235000011187 glycerol Nutrition 0.000 description 9
- 239000006210 lotion Substances 0.000 description 9
- 229960005323 phenoxyethanol Drugs 0.000 description 9
- 229940058015 1,3-butylene glycol Drugs 0.000 description 8
- 235000019437 butane-1,3-diol Nutrition 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- 238000002156 mixing Methods 0.000 description 7
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 6
- 239000004359 castor oil Substances 0.000 description 6
- 235000019438 castor oil Nutrition 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 230000000475 sunscreen effect Effects 0.000 description 6
- 239000000516 sunscreening agent Substances 0.000 description 6
- 239000006096 absorbing agent Substances 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 239000004006 olive oil Substances 0.000 description 5
- 235000008390 olive oil Nutrition 0.000 description 5
- 229920001296 polysiloxane Polymers 0.000 description 5
- 239000002453 shampoo Substances 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- XEFAJZOBODPHBG-UHFFFAOYSA-N 1-phenoxyethanol Chemical compound CC(O)OC1=CC=CC=C1 XEFAJZOBODPHBG-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 229920002385 Sodium hyaluronate Polymers 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229940010747 sodium hyaluronate Drugs 0.000 description 4
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 4
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 229920000858 Cyclodextrin Polymers 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000000419 plant extract Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 229940071139 pyrrolidone carboxylate Drugs 0.000 description 3
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000001509 sodium citrate Substances 0.000 description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 239000011787 zinc oxide Substances 0.000 description 3
- 229940015975 1,2-hexanediol Drugs 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 2
- MDVYIGJINBYKOM-IBSWDFHHSA-N 3-[(1r,2s,5r)-5-methyl-2-propan-2-ylcyclohexyl]oxypropane-1,2-diol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OCC(O)CO MDVYIGJINBYKOM-IBSWDFHHSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical group CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 206010042496 Sunburn Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 239000003788 bath preparation Substances 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 229940124274 edetate disodium Drugs 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 2
- 125000006353 oxyethylene group Chemical group 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241000256844 Apis mellifera Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000219104 Cucurbitaceae Species 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- 235000019766 L-Lysine Nutrition 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000013040 bath agent Substances 0.000 description 1
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229940072104 cholesteryl hydroxystearate Drugs 0.000 description 1
- 230000037319 collagen production Effects 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 1
- SMVRDGHCVNAOIN-UHFFFAOYSA-L disodium;1-dodecoxydodecane;sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC SMVRDGHCVNAOIN-UHFFFAOYSA-L 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 229940074052 glyceryl isostearate Drugs 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 1
- 229940057838 polyethylene glycol 4000 Drugs 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 230000037373 wrinkle formation Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
Images
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
本発明は、ヘチマ根部の抽出物を含有し、紫外線炎症抑制などに優れた抗炎症皮膚外用剤に関する。 The present invention relates to an anti-inflammatory skin external preparation which contains an extract of a loofah root and is excellent in suppressing ultraviolet inflammation.
近年、オゾン層の減少により、地表に到達する太陽光紫外線量は年々増加している。紫外線を浴びすぎると、皮膚は傷つき、紅斑と呼ばれる炎症が発生し、肌が荒れ、皮膚保湿機能が低下する。また、コラーゲン産生の低下なども引き起こし、シワが形成される。これらのように、紫外線は皮膚に悪影響を及ぼすことから、近年では日焼け止め化粧料や日焼け後のスキンケア化粧料等の日焼けに関連する化粧料の需要が増加している。 In recent years, the amount of solar ultraviolet rays reaching the surface of the earth has been increasing year by year due to a decrease in the ozone layer. When exposed to too much UV light, the skin is damaged, inflammation called erythema occurs, the skin becomes rough, and the skin moisturizing function decreases. It also causes a decrease in collagen production and wrinkles are formed. As described above, since ultraviolet rays have an adverse effect on the skin, in recent years, there has been an increasing demand for cosmetics related to sunburn such as sunscreen cosmetics and skin care cosmetics after sunburn.
従来、日焼け止め化粧料には、各種の紫外線散乱剤や紫外線吸収剤が配合されてきた。紫外線散乱剤や紫外線吸収剤は、皮膚が紫外線に暴露されることを軽減させる効果はある。しかし紫外線散乱剤の配合量が多くなると油分の配合量も増加するため使用感が悪化する。 Conventionally, sunscreen cosmetics have been blended with various UV scattering agents and UV absorbers. UV scattering agents and UV absorbers have the effect of reducing the exposure of the skin to UV rays. However, when the blending amount of the ultraviolet scattering agent is increased, the blending amount of the oil is also increased, so that the feeling of use is deteriorated.
紫外線散乱剤や紫外線吸収剤は紫外線から皮膚を防御することを目的としたものであるが、これとは別に、紫外線を浴びた皮膚への悪影響を抑制する物質が研究されている。これら物質を日焼け止めに配合することによって紫外線散乱剤や紫外線吸収剤の配合量を低減させることができ、また、スキンケア化粧料に配合することによって紫外線による皮膚への影響を抑制することができる。 Ultraviolet scattering agents and ultraviolet absorbers are intended to protect the skin from ultraviolet rays, but apart from this, substances that suppress adverse effects on the skin exposed to ultraviolet rays have been studied. By blending these substances into sunscreens, the blending amount of UV scattering agent and UV absorber can be reduced, and by blending in skin care cosmetics, the influence of UV rays on the skin can be suppressed.
一方、一般に植物由来成分は皮膚への刺激が少ないと考えられており、多種の植物抽出物がスキンケア化粧料に配合されている。例えば、ヘチマの果実又は茎から浸出する液汁であるヘチマ水にε−アミノカプロン酸、グリチルリチン酸などの特定成分を加えた化粧料が知られている(特許文献1)。また、ヘチマ全草抽出物と他の植物抽出物を含有する化粧料が知られている(特許文献2)。
しかしながら、ヘチマ根部の抽出物に抗炎症作用が存在することは知られていなかった。従って、本発明は、ヘチマ根部の抽出物を含有する抗炎症皮膚外用剤、特に紫外線による炎症を抑制する皮膚外用剤の提供を目的とする。 However, it has not been known that the extract of loofah root has an anti-inflammatory effect. Accordingly, an object of the present invention is to provide an anti-inflammatory skin external preparation containing an extract of loofah root, particularly a skin external preparation that suppresses inflammation caused by ultraviolet rays.
本発明者は、上記従来技術の問題点に鑑み鋭意検討を重ねた結果、ヘチマ根部の抽出物が抗炎症作用、特に紫外線による紅斑を抑制する作用を示すことを見出した。 As a result of intensive studies in view of the above-mentioned problems of the prior art, the present inventor has found that the extract of loofah root exhibits an anti-inflammatory action, particularly an action of suppressing erythema caused by ultraviolet rays.
すなわち、本発明は、下記の抗炎症皮膚外用剤を提供するものである。
項1.ヘチマ根部の抽出物を含有する抗炎症皮膚外用剤。
項2.ヘチマ根部の抽出物がエタノール、ブタノール及び水からなる群から選択される少なくとも1種の溶媒の抽出物である項1に記載の抗炎症皮膚外用剤。
項3.炎症が紫外線による炎症である項1又は2に記載の抗炎症皮膚外用剤。
項4.皮膚外用剤が皮膚化粧料である項1〜3のいずれかに記載の抗炎症皮膚外用剤
本発明の抗炎症皮膚外用剤は、ヘチマ根部の抽出物を含有することを特徴とする。ヘチマ(Luffa cylindrica M. Roemen)はウリ科(Cucurbitaceae)に属する草本である。また、ヘチマ根部はヘチマの根を意味する。
That is, this invention provides the following anti-inflammatory skin external preparation.
Item 2. Item 2. The anti-inflammatory skin external preparation according to
Item 3. Item 3. The anti-inflammatory skin external preparation according to
ヘチマ根部は生のまま抽出に供してもよいが、細切、乾燥、粉砕などの抽出に適した処理を行ってから抽出することが好ましい。通常、上記処理された又は被処理のヘチマ根部を抽出溶媒に接触させ、静置、振盪、超音波照射、加熱、加圧等やそれらを組み合わせることによって抽出する。好ましくは、浸漬し、振盪または撹拌する方法である。 The loof root part may be subjected to extraction as it is, but it is preferable to perform extraction after performing a treatment suitable for extraction, such as chopping, drying, and grinding. Usually, the above-treated or to-be-treated loofah root is brought into contact with an extraction solvent and extracted by standing, shaking, ultrasonic irradiation, heating, pressurization, or the like, or a combination thereof. Preferably, it is a method of immersing, shaking or stirring.
抽出溶媒としては、通常、水、有機溶媒などを単独又は2種以上併用して用いる。有機溶媒は、通常、メタノール、エタノール、プロパノール、イソプロパノール、ブタノール等の低級アルコール類ポリエチレングリコール、プロピレングリコール、1,3−ブチレングリコール、ジプロピレングリコール等の多価アルコール類;石油エーテル、シクロヘキサン、トルエン、ベンゼン等の炭化水素類;エチルエーテル、プロピルエーテル等のエーテル類;ジクロロメタン、クロロホルム、四塩化炭素等のハロゲン化炭化水素類;酢酸エチル、酢酸ブチル等のエステル類;アセトン、メチルエチルケトン等のケトン類;CO2等の超臨界流体などが使用できる。好ましい抽出溶媒はエタノール、ブタノール、水であり、単独で又は2種以上混合して使用できる。より好ましい抽出溶媒はエタノール、水、含水エタノールである。 As the extraction solvent, water, an organic solvent or the like is usually used alone or in combination of two or more. The organic solvent is usually a lower alcohol such as methanol, ethanol, propanol, isopropanol, or butanol, a polyhydric alcohol such as propylene glycol, 1,3-butylene glycol, or dipropylene glycol; petroleum ether, cyclohexane, toluene, Hydrocarbons such as benzene; ethers such as ethyl ether and propyl ether; halogenated hydrocarbons such as dichloromethane, chloroform and carbon tetrachloride; esters such as ethyl acetate and butyl acetate; ketones such as acetone and methyl ethyl ketone; A supercritical fluid such as CO 2 can be used. Preferred extraction solvents are ethanol, butanol, and water, which can be used alone or in combination of two or more. More preferred extraction solvents are ethanol, water, and hydrous ethanol.
抽出温度は、通常、3℃〜溶媒の沸点である。抽出時間は、抽出溶媒の種類、抽出温度、ヘチマ根部の形態などによって異なるが、通常1時間〜7日間、好ましくは2時間〜3日間である。また、必要に応じて加圧することもできる。 The extraction temperature is usually 3 ° C. to the boiling point of the solvent. The extraction time varies depending on the type of the extraction solvent, the extraction temperature, the shape of the loofah root, etc., but is usually 1 hour to 7 days, preferably 2 hours to 3 days. Moreover, it can also pressurize as needed.
上記抽出溶媒による抽出物は、そのままでも本発明におけるヘチマ根部の抽出物として使用することができるが、濃縮、乾固、凍結乾燥したものを水、有機溶媒等に溶解したり、抽出物の有する抗炎症効果を損なわない範囲で脱色、脱臭、脱塩等の精製処理を行ったり、液・液分配、カラムクロマトグラフィーによる分画処理などを行って得られたものを使用することもできる。また、リポソーム等の担体やマイクロカプセル等に内包させて使用することもできる。 The extract by the above extraction solvent can be used as it is as the extract of the root of the loofah in the present invention, but the concentrated, dried, freeze-dried product can be dissolved in water, an organic solvent, or the like. It is also possible to use those obtained by performing purification treatments such as decolorization, deodorization, desalting, etc. within the range not impairing the anti-inflammatory effect, or liquid / liquid distribution, fractionation treatment by column chromatography, and the like. It can also be used by being encapsulated in a carrier such as a liposome or a microcapsule.
本発明の抗炎症皮膚外用剤は、ヘチマ根部の抽出物を含有することにより皮膚の炎症、特に紫外線に基づく皮膚の炎症、を抑制する作用を有する。このため、本発明の抗炎症皮膚外用剤は皮膚への適用に適した剤型、例えば、ゲル剤、クリーム剤、軟膏剤、リニメント剤、ローション剤、乳剤、粉剤、懸濁剤、エアゾール剤、硬膏剤、パップ剤、テープ剤、プラスター剤などで使用できる。好ましくは、ゲル剤、クリーム剤、乳剤である。また、本発明の抗炎症皮膚外用剤は、化粧水、乳液、クリーム、美容液、パック、メイクアップベースローション、メイクアップベースクリーム、ファンデーション、アイカラー、チークカラー、リップスティック、日焼け止め等の皮膚化粧料、クレンジングローション、クレンジングクリーム、クレンジングフォーム、洗顔石鹸、ボディーシャンプー等の皮膚洗浄料、ヘアーシャンプー、ヘアーリンス、ヘアートリートメント等の毛髪用化粧料、浴用剤などとして使用できる。好ましくはクリーム、美容液、日焼け止めである。 The anti-inflammatory skin external preparation of this invention has the effect | action which suppresses the inflammation of skin, especially the inflammation of the skin based on an ultraviolet-ray by containing the extract of a loofah root. For this reason, the anti-inflammatory skin external preparation of the present invention has a dosage form suitable for application to the skin, such as a gel, cream, ointment, liniment, lotion, emulsion, powder, suspension, aerosol, Can be used in plasters, poultices, tapes, plasters, etc. Preferred are gels, creams, and emulsions. Further, the anti-inflammatory skin external preparation of the present invention is used for skin lotions, emulsions, creams, serums, packs, makeup base lotions, makeup base creams, foundations, eye colors, cheek colors, lipsticks, sunscreens, etc. It can be used as cosmetics, cleansing lotions, cleansing creams, cleansing foams, facial soaps, body shampoos and other skin cleansers, hair shampoos, hair rinses, hair treatments and other hair cosmetics, bath preparations and the like. Creams, serums and sunscreens are preferred.
本発明の抗炎症皮膚外用剤におけるヘチマ根部の抽出物の配合量は抗炎症作用が発揮される限り制限されないが、溶媒抽出液を使用する場合、通常、0.0001〜5重量%、好ましくは0.01〜1重量%、より好ましくは0.05〜0.6重量%であり、溶媒抽出物の乾燥固形物を使用する場合、通常、0.0001〜0.03重量%、好ましくは0.0005〜0.018重量%である。 The blending amount of the loofah root extract in the anti-inflammatory skin external preparation of the present invention is not limited as long as the anti-inflammatory action is exerted, but when a solvent extract is used, it is usually 0.0001 to 5% by weight, preferably 0.01 to 1% by weight, more preferably 0.05 to 0.6% by weight. When a dry solid of the solvent extract is used, it is usually 0.0001 to 0.03% by weight, preferably 0 .0005 to 0.018% by weight.
また、本発明の抗炎症皮膚外用剤の投与量は特に制限されず、1日1回又は数回に分けて投与することができる。 The dosage of the anti-inflammatory skin external preparation of the present invention is not particularly limited, and can be administered once or several times a day.
本発明の抗炎症皮膚外用剤には、皮膚外用剤の成分として一般に使用される成分を、本発明の効果が発揮される範囲の配合量で配合することができる。このような成分としては、界面活性剤、水溶性高分子、着色剤、酸化防止剤、金属封鎖剤、防腐剤、pH調整剤、清涼剤、香料、保湿剤、紫外線吸収剤、紫外線散乱剤、抗酸化剤などが使用できる。また、皮膚外用剤の他の有効成分を本発明の効果が発揮される範囲の配合量で配合することもできる。このような有効成分としては、美白剤、抗炎症剤、シワ形成抑制剤、脂肪分解剤、育毛剤などが使用できる。 In the anti-inflammatory skin external preparation of the present invention, components generally used as components of the skin external preparation can be blended in a blending amount within a range in which the effects of the present invention are exhibited. Examples of such components include surfactants, water-soluble polymers, colorants, antioxidants, sequestering agents, preservatives, pH adjusters, refreshing agents, fragrances, moisturizers, ultraviolet absorbers, ultraviolet scattering agents, Antioxidants can be used. Moreover, the other active ingredient of a skin external preparation can also be mix | blended with the compounding quantity of the range in which the effect of this invention is exhibited. Examples of such active ingredients include whitening agents, anti-inflammatory agents, wrinkle formation inhibitors, lipolytic agents, and hair restorers.
本発明の抗炎症皮膚外用剤は皮膚の炎症を予防又は抑制することができ、特に紫外線に起因する炎症(例えば、紫外線による紅斑)の予防又は抑制に効果が高い。 The anti-inflammatory skin external preparation of the present invention can prevent or suppress skin inflammation, and is particularly effective in preventing or suppressing inflammation caused by ultraviolet rays (for example, erythema due to ultraviolet rays).
以下、実施例を挙げてより詳細に本発明を説明するが、本発明はこれら実施例に限定されるものではない。 EXAMPLES Hereinafter, although an Example is given and this invention is demonstrated in detail, this invention is not limited to these Examples.
製造例1(ヘチマ根部の抽出物)
ヘチマの根部を乾燥し、粉砕した。粉砕物1kgを95%エタノール20L中に浸漬し、25℃で3日間抽出した後、ろ過して濾液を回収し、ヘチマ根部抽出物を得た。
Production Example 1 (Extract of loofah root)
The loofah roots were dried and ground. 1 kg of the pulverized product was immersed in 20 L of 95% ethanol, extracted at 25 ° C. for 3 days, filtered, and the filtrate was collected to obtain a loofah root extract.
実施例1(ヘチマ根部の抽出物の抗炎症作用)
製造例1で得られたヘチマ根部の抽出物に95%エタノールを添加し、該抽出物を0.2重量%及び0.3重量%含有するサンプルを調製した。また、コントロールとして95%エタノールを使用した。サンプル塗布前の被験者の背部の赤みの程度を色差計CR−200(ミノルタ製)で測定した後(測定値をa0とする)、測定部位に20μlのサンプル又はコントロールを塗布し1時間経過後、95%エタノールを含んだ脱脂綿でサンプル塗布部位を拭き取り、予め測定しておいた被験者の最小紅斑量(MED:皮膚に紅斑を引き起こす最も少ない紫外線量)に相当する紫外線量を塗布部位に照射した。紫外線照射の6時間後のサンプル塗布部位の赤みの程度を色差計で測定し(測定値をa6とする)、得られた測定値からサンプル塗布前の測定値を差し引き、赤みの変化の程度(色差:Δa)を算出した(Δa=a6−a0)。算出された色差を表1及び図1に示す。なお、各サンプル毎に3人の被験者に協力してもらった。表1及び図1は色差の平均値を示している。
Example 1 (Anti-inflammatory effect of loofah root extract)
95% ethanol was added to the extract of the loofah root obtained in Production Example 1 to prepare samples containing 0.2% by weight and 0.3% by weight of the extract. In addition, 95% ethanol was used as a control. Sample pre-application of the subject's back of red color-difference meter CR-200 degrees after the measurement (manufactured by Minolta) (measured values and a 0), coated with 20μl of sample or control the measurement site after one hour The sample application site was wiped off with absorbent cotton containing 95% ethanol, and the application site was irradiated with an amount of ultraviolet rays corresponding to the minimum amount of erythema (MED: the smallest amount of ultraviolet rays that causes erythema on the skin) measured in advance. . The degree of redness of the sample application site after 6 hours of UV irradiation was measured by a color difference meter (measured value and a 6), subtracting the measured value before the sample application from the measurements obtained, the degree of redness of change (Color difference: Δa) was calculated (Δa = a 6 −a 0 ). The calculated color difference is shown in Table 1 and FIG. In addition, three subjects cooperated for each sample. Table 1 and FIG. 1 show average values of color differences.
この結果から、ヘチマ根部の抽出物の塗布により紫外線による皮膚の紅斑の程度が抑制されることが確認された。 From this result, it was confirmed that the degree of erythema of the skin due to ultraviolet rays was suppressed by applying the extract of the loofah root.
以下、処方例を示す。なお、各処方は常法により調製され、各成分の量は重量%である。なお、ヘチマ根部抽出物は製造例1で得られた抽出物を使用した。 Hereinafter, a prescription example is shown. Each formulation is prepared by a conventional method, and the amount of each component is% by weight. The extract obtained in Production Example 1 was used as the loofah root extract.
処方例1(化粧水)
ヘチマ根部抽出物 0.3
エタノール 5.0
濃グリセリン 4.0
ポリエチレングリコール1500 3.0
ヒアルロン酸ナトリウム 0.1
ポリオキシエチレン硬化ヒマシ油(60E.O.) 0.3
トレハロース 1.0
香料 0.03
フェノキシエタノール 0.7
クエン酸 0.08
クエン酸ナトリウム 0.08
精製水 残部
計 100.0
Formulation Example 1 (Lotion)
Loofah root extract 0.3
Ethanol 5.0
Concentrated glycerin 4.0
Polyethylene glycol 1500 3.0
Sodium hyaluronate 0.1
Polyoxyethylene hydrogenated castor oil (60 EO) 0.3
Trehalose 1.0
Perfume 0.03
Phenoxyethanol 0.7
Citric acid 0.08
Sodium citrate 0.08
Purified water balance
Total 100.0
処方例2(化粧水)
ヘチマ根部抽出物 0.3
エタノール 17.0
1,3−ブチレングリコール 2.0
アセチル化ヒアルロン酸ナトリウム 0.01
ポリオキシエチレン硬化ヒマシ油(60E.O.) 0.3
ポリオキシエチレン硬化ヒマシ油(40E.O.) 0.05
香料 0.03
メントキシプロパンジオール 0.02
フェノキシエタノール 0.5
クエン酸 0.08
クエン酸ナトリウム 0.2
アラントイン 0.02
dl−ピロリドンカルボン酸ナトリウム液 0.1
ゲンチアナエキス 0.1
精製水 残部
計 100.0
Formulation Example 2 (Lotion)
Loofah root extract 0.3
Ethanol 17.0
1,3-butylene glycol 2.0
Acetylated sodium hyaluronate 0.01
Polyoxyethylene hydrogenated castor oil (60 EO) 0.3
Polyoxyethylene hydrogenated castor oil (40E.O.) 0.05
Perfume 0.03
Menthoxypropanediol 0.02
Phenoxyethanol 0.5
Citric acid 0.08
Sodium citrate 0.2
Allantoin 0.02
dl-Pyrrolidonecarboxylate sodium solution 0.1
Gentian extract 0.1
Purified water balance
Total 100.0
処方例3(美容液)
ヘチマ根部抽出物 0.3
エタノール 10.0
濃グリセリン 10.0
1,3−ブチレングリコール 6.0
dl−ピロリドンカルボン酸ナトリウム 0.5
ポリオキシエチレン硬化ヒマシ油(60E.O.) 0.5
キサンタンガム 0.4
寒天末 2.0
ヒアルロン酸ナトリウム 0.1
クエン酸 0.08
クエン酸ナトリウム 0.08
水素添加大豆リン脂質 0.5
シクロデキストリン 0.1
香料 0.1
フェノキシエタノール 0.8
精製水 残部
計 100.0
Formulation Example 3 (Cosmetic liquid)
Loofah root extract 0.3
Ethanol 10.0
Concentrated glycerin 10.0
1,3-butylene glycol 6.0
dl-Pyrrolidonecarboxylate sodium 0.5
Polyoxyethylene hydrogenated castor oil (60 EO) 0.5
Xanthan gum 0.4
Agar powder 2.0
Sodium hyaluronate 0.1
Citric acid 0.08
Sodium citrate 0.08
Hydrogenated soybean phospholipid 0.5
Cyclodextrin 0.1
Fragrance 0.1
Phenoxyethanol 0.8
Purified water balance
Total 100.0
処方例4(美容液)
ヘチマ根部抽出物 0.3
エタノール 8.0
1,3−ブチレングリコール 5.0
濃グリセリン 5.0
カルボキシビニルポリマー 0.5
フェノキシエタノール 0.5
水酸化カリウム 0.3
ポリオキシエチレン硬化ヒマシ油(60E.O.) 0.3
ポリオキシエチレン硬化ヒマシ油(40E.O.) 0.1
メントキシプロパンジオール 0.2
エンブリコエキス 0.1
香料 0.1
エデト酸二ナトリウム 0.05
クエン酸 0.05
精製水 残部
計 100.0
Formulation Example 4 (Cosmetic liquid)
Loofah root extract 0.3
Ethanol 8.0
1,3-butylene glycol 5.0
Concentrated glycerin 5.0
Carboxyvinyl polymer 0.5
Phenoxyethanol 0.5
Potassium hydroxide 0.3
Polyoxyethylene hydrogenated castor oil (60 EO) 0.3
Polyoxyethylene hydrogenated castor oil (40E.O.) 0.1
Menthoxypropanediol 0.2
Embryo extract 0.1
Fragrance 0.1
Edetate disodium 0.05
Citric acid 0.05
Purified water balance
Total 100.0
処方例5(乳液)
ヘチマ根部抽出物 0.3
1,3−ブチレングリコール 12.0
カルボキシビニルポリマー 0.2
ステアリン酸 1.0
エタノール 3.0
オリーブ油 8.0
トリ(カプリル/カプリン酸)グリセリン 1.0
メチルポリシロキサン 2.0
レシチン 0.1
バチルアルコール 1.0
シクロデキストリン 0.5
水酸化カリウム 0.2
クエン酸 0.1
ヒアルロン酸ナトリウム 0.1
香料 0.1
フェノキシエタノール 0.7
精製水 残部
計 100.0
Formulation Example 5 (Emulsion)
Loofah root extract 0.3
1,3-butylene glycol 12.0
Carboxyvinyl polymer 0.2
Stearic acid 1.0
Ethanol 3.0
Olive oil 8.0
Tri (Capryl / Capric acid) Glycerin 1.0
Methylpolysiloxane 2.0
Lecithin 0.1
Batyl alcohol 1.0
Cyclodextrin 0.5
Potassium hydroxide 0.2
Citric acid 0.1
Sodium hyaluronate 0.1
Fragrance 0.1
Phenoxyethanol 0.7
Purified water balance
Total 100.0
処方例6(クリーム)
ヘチマ根部抽出物 0.3
濃グリセリン 10.0
モノステアリン酸ポリグリセリル 4.0
親油性モノステアリン酸グリセリル 4.0
ステアリン酸 4.0
スクワラン 6.0
オリーブ油 8.0
メチルポリシロキサン 0.7
セタノール 3.0
エタノール 3.0
シクロデキストリン 0.1
香料 0.1
水酸化カリウム 0.6
カルボキシビニルポリマー 0.2
dl−ピロリドンカルボン酸ナトリウム 0.1
クエン酸 0.1
フェノキシエタノール 0.9
1,2−ヘキサンジオール 1.0
ヒドロキシステアリン酸コレステリル 0.5
ダイマージリノール酸(フィトステリル/
イソステアリル/セチル/ステアリル/ベヘニル) 0.4
精製水 残部
計 100.0
Formulation Example 6 (Cream)
Loofah root extract 0.3
Concentrated glycerin 10.0
Polyglyceryl monostearate 4.0
Lipophilic glyceryl monostearate 4.0
Stearic acid 4.0
Squalane 6.0
Olive oil 8.0
Methyl polysiloxane 0.7
Cetanol 3.0
Ethanol 3.0
Cyclodextrin 0.1
Fragrance 0.1
Potassium hydroxide 0.6
Carboxyvinyl polymer 0.2
dl-Pyrrolidonecarboxylate sodium 0.1
Citric acid 0.1
Phenoxyethanol 0.9
1,2-hexanediol 1.0
Cholesteryl hydroxystearate 0.5
Dimer linoleic acid (phytosteryl /
(Isostearyl / cetyl / stearyl / behenyl) 0.4
Purified water balance
Total 100.0
処方例7(洗顔フォーム)
ヘチマ根部抽出物 0.3
ステアリン酸 10.0
パルミチン酸 12.0
ミリスチン酸 15.0
ラウリン酸 3.0
ラウリルジメチルアミンオキシド液 5.0
サラシミツロウ 2.0
ポリエチレングリコール4000 4.0
水酸化カリウム 8.0
香料 0.6
フェノキシエタノール 0.9
1,3−ブチレングリコール 4.0
1,2−ヘキサンジオール 1.0
濃グリセリン 5.0
ヤシ油脂肪酸サルコシンナトリウム 3.0
クエン酸 0.1
エタノール 2.0
エデト酸二ナトリウム 0.2
精製水 残部
計 100.0
Formulation Example 7 (Fashion Cleansing Foam)
Loofah root extract 0.3
Stearic acid 10.0
Palmitic acid 12.0
Myristic acid 15.0
Lauric acid 3.0
Lauryldimethylamine oxide solution 5.0
Sara honey bee 2.0
Polyethylene glycol 4000 4.0
Potassium hydroxide 8.0
Fragrance 0.6
Phenoxyethanol 0.9
1,3-butylene glycol 4.0
1,2-hexanediol 1.0
Concentrated glycerin 5.0
Coconut oil fatty acid sarcosine sodium 3.0
Citric acid 0.1
Ethanol 2.0
Edetate disodium 0.2
Purified water balance
Total 100.0
処方例8(クレンジングジェル)
ヘチマ根部抽出物 0.3
エタノール 5.0
ジプロピレングリコール 17.0
ポリオキシエチレンヤシ油脂肪酸グリセリン(7E.O.) 15.0
濃グリセリン 17.0
カルボキシビニルポリマー 1.0
Nε―ラウロイルーL−リジン 0.1
オリーブ油 2.0
マカデミアナッツ油 1.0
クエン酸 0.1
水酸化ナトリウム 0.5
フェノキシエタノール 0.9
香料 0.1
精製水 残部
計 100.0
Formulation Example 8 (Cleansing Gel)
Loofah root extract 0.3
Ethanol 5.0
Dipropylene glycol 17.0
Polyoxyethylene coconut oil fatty acid glycerin (7EO) 15.0
Concentrated glycerin 17.0
Carboxyvinyl polymer 1.0
Nε-Lauroy roux L-lysine 0.1
Olive oil 2.0
Macadamia nut oil 1.0
Citric acid 0.1
Sodium hydroxide 0.5
Phenoxyethanol 0.9
Fragrance 0.1
Purified water balance
Total 100.0
処方例9(化粧下地)
ヘチマ根部抽出物 0.3
デカメチルシクロペンタシロキサン 45.0
酸化チタン 2.0
酸化亜鉛 26.0
ポリ(オキシエチレン・オキシプロピレン)
メチルポリシロキサン共重合体 0.5
オリーブ油 3.0
モノイソステアリン酸ポリグリセリル 2.0
1,3−ブチレングリコール 5.0
塩化ナトリウム 0.5
濃グリセリン 1.0
エタノール 1.0
フェノキシエタノール 0.8
クエン酸 0.1
精製水 残部
計 100.0
Formulation example 9 (makeup base)
Loofah root extract 0.3
Decamethylcyclopentasiloxane 45.0
Titanium oxide 2.0
Zinc oxide 26.0
Poly (oxyethylene / oxypropylene)
Methyl polysiloxane copolymer 0.5
Olive oil 3.0
Polyglyceryl monoisostearate 2.0
1,3-butylene glycol 5.0
Sodium chloride 0.5
Concentrated glycerin 1.0
Ethanol 1.0
Phenoxyethanol 0.8
Citric acid 0.1
Purified water balance
Total 100.0
処方例10(パウダーファンデーション)
ヘチマ根部抽出物 0.3
酸化チタン 10.0
セリサイト 40.0
酸化亜鉛 10.0
タルク 残部
酸化アルミニウム 1.0
酸化鉄 5.0
ベンガラ 2.0
メチルポリシロキサン 1.0
メチルハイドロジェンポリシロキサン 1.0
イソステアリン酸グリセリル 0.5
エタノール 0.1
植物性スクワラン 2.0
オリーブ油 0.1
フェノキシエタノール 0.1
計 100.0
Formulation Example 10 (Powder Foundation)
Loofah root extract 0.3
Titanium oxide 10.0
Sericite 40.0
Zinc oxide 10.0
Talc balance Aluminum oxide 1.0
Iron oxide 5.0
Bengala 2.0
Methylpolysiloxane 1.0
Methyl hydrogen polysiloxane 1.0
Glyceryl isostearate 0.5
Ethanol 0.1
Plant-based squalane 2.0
Olive oil 0.1
Phenoxyethanol 0.1
Total 100.0
処方例11(リキッドファンデーション)
ヘチマ根部抽出物 0.3
デカメチルシクロペンタシロキサン 35.0
酸化チタン 8.0
酸化亜鉛 5.0
酸化鉄 3.0
塩化ナトリウム 0.5
エタノール 1.0
フェノキシエタノール 0.5
メチルポリシロキサン・セチルメチルポリシロキサン・
ポリ(オキシエチレン・オキシプロピレン)
メチルポリシロキサン共重合体 3.5
植物性スクワラン 5.0
1,3−ブチレングリコール 5.0
1,2−ペンタンジオール 3.0
セリサイト 3.0
ジイソステアリン酸ポリグリセリル 2.0
精製水 残部
計 100.0
Formulation Example 11 (Liquid Foundation)
Loofah root extract 0.3
Decamethylcyclopentasiloxane 35.0
Titanium oxide 8.0
Zinc oxide 5.0
Iron oxide 3.0
Sodium chloride 0.5
Ethanol 1.0
Phenoxyethanol 0.5
Methyl polysiloxane, cetyl methyl polysiloxane,
Poly (oxyethylene / oxypropylene)
Methylpolysiloxane copolymer 3.5
Plant-based squalane 5.0
1,3-butylene glycol 5.0
1,2-pentanediol 3.0
Sericite 3.0
Polyglyceryl diisostearate 2.0
Purified water balance
Total 100.0
処方例12(シャンプー)
ヘチマ根部抽出物 0.3
ポリオキシエチレン(3E.O.)
ラウリルエーテル硫酸ナトリウム 15.0
ヤシ油脂肪アミドプロピルジメチルアミノ酢酸ベタイン 5.0
ヤシ油脂肪酸ジエタノールアミド 3.0
プロピレングリコール 8.0
フェノキシエタノール 0.8
香料 0.7
精製水 残部
計 100.0
Formulation Example 12 (Shampoo)
Loofah root extract 0.3
Polyoxyethylene (3E.O.)
Sodium lauryl ether sulfate 15.0
Palm oil fat amidopropyldimethylaminoacetic acid betaine 5.0
Palm oil fatty acid diethanolamide 3.0
Propylene glycol 8.0
Phenoxyethanol 0.8
Fragrance 0.7
Purified water balance
Total 100.0
処方例13(ヘアコンディショナー)
ヘチマ根部抽出物 0.3
プロピレングリコール 3.0
ポリオキシエチレン(5E.O)オレイルエーテル 2.5
セタノール 2.5
トリカプリル酸グリセリル 5.0
塩化ステアリルトリメチルアンモニウム 4.0
クエン酸 0.15
香料 0.5
フェノキシエタノール 0.8
精製水 残部
計 100.0
Formulation Example 13 (hair conditioner)
Loofah root extract 0.3
Propylene glycol 3.0
Polyoxyethylene (5E.O) oleyl ether 2.5
Cetanol 2.5
Glyceryl tricaprylate 5.0
Stearyltrimethylammonium chloride 4.0
Citric acid 0.15
Fragrance 0.5
Phenoxyethanol 0.8
Purified water balance
Total 100.0
処方例14(入浴剤)
ヘチマ根部抽出物 0.3
硫酸ナトリウム 50.0
炭酸水素ナトリウム 残部
酸化チタン 1.0
香料 0.7
計 100.0
Formulation Example 14 (Bath Agent)
Loofah root extract 0.3
Sodium sulfate 50.0
Sodium bicarbonate The remainder Titanium oxide 1.0
Fragrance 0.7
Total 100.0
本発明の抗炎症皮膚外用剤は抗炎症性を有する化粧水、乳液、クリーム、美容液、パック、メイクアップベースローション、メイクアップベースクリーム、ファンデーション、アイカラー、チークカラー、リップスティック、日焼け止め等の皮膚化粧料、クレンジングローション、クレンジングクリーム、クレンジングフォーム、洗顔石鹸、ボディーシャンプー等の皮膚洗浄料、ヘアーシャンプー、ヘアーリンス、ヘアートリートメント等の毛髪用化粧料、浴用剤などとして使用できる。 Anti-inflammatory skin external preparation of the present invention has anti-inflammatory skin lotion, emulsion, cream, serum, pack, makeup base lotion, makeup base cream, foundation, eye color, cheek color, lipstick, sunscreen, etc. Skin cosmetics, cleansing lotions, cleansing creams, cleansing foams, facial soaps, body shampoos and other skin cleansing agents, hair shampoos, hair rinses, hair treatments and other cosmetics for hair, bath preparations and the like.
Claims (4)
The anti-inflammatory skin external preparation according to any one of claims 1 to 3, wherein the skin external preparation is a skin cosmetic.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004238725A JP4716692B2 (en) | 2004-08-18 | 2004-08-18 | Anti-inflammatory skin external preparation containing loofah root extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004238725A JP4716692B2 (en) | 2004-08-18 | 2004-08-18 | Anti-inflammatory skin external preparation containing loofah root extract |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2006056808A true JP2006056808A (en) | 2006-03-02 |
JP4716692B2 JP4716692B2 (en) | 2011-07-06 |
Family
ID=36104582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004238725A Expired - Lifetime JP4716692B2 (en) | 2004-08-18 | 2004-08-18 | Anti-inflammatory skin external preparation containing loofah root extract |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4716692B2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013256472A (en) * | 2012-06-13 | 2013-12-26 | Yakult Honsha Co Ltd | Thickening composition containing acylated amino acid |
KR20190089425A (en) * | 2018-01-22 | 2019-07-31 | 정대화 | Vasodilator and antiphlogistics containing extract of luffa cylindrica |
CN110980979A (en) * | 2019-12-20 | 2020-04-10 | 衢州市农业科学研究院 | Method and equipment for treating loofah liquid stock solution |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115066228A (en) | 2020-02-25 | 2022-09-16 | 科莱恩国际有限公司 | Composition comprising luffa root extract |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61289010A (en) * | 1985-06-15 | 1986-12-19 | Nonogawa Shoji:Kk | Cosmetic |
JPS62226912A (en) * | 1986-03-29 | 1987-10-05 | Nonogawa Shoji:Kk | Cosmetic blended with extract of culture root of cucurbitaceous plant |
JPH06345630A (en) * | 1993-06-03 | 1994-12-20 | Sunstar Inc | Anti-inflammatory composition for oral cavity |
-
2004
- 2004-08-18 JP JP2004238725A patent/JP4716692B2/en not_active Expired - Lifetime
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61289010A (en) * | 1985-06-15 | 1986-12-19 | Nonogawa Shoji:Kk | Cosmetic |
JPS62226912A (en) * | 1986-03-29 | 1987-10-05 | Nonogawa Shoji:Kk | Cosmetic blended with extract of culture root of cucurbitaceous plant |
JPH06345630A (en) * | 1993-06-03 | 1994-12-20 | Sunstar Inc | Anti-inflammatory composition for oral cavity |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013256472A (en) * | 2012-06-13 | 2013-12-26 | Yakult Honsha Co Ltd | Thickening composition containing acylated amino acid |
KR20190089425A (en) * | 2018-01-22 | 2019-07-31 | 정대화 | Vasodilator and antiphlogistics containing extract of luffa cylindrica |
KR102147868B1 (en) | 2018-01-22 | 2020-08-25 | 정대화 | Vasodilator and antiphlogistics containing extract of luffa cylindrica |
CN110980979A (en) * | 2019-12-20 | 2020-04-10 | 衢州市农业科学研究院 | Method and equipment for treating loofah liquid stock solution |
Also Published As
Publication number | Publication date |
---|---|
JP4716692B2 (en) | 2011-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105392531B (en) | For highlighting the composition of skin and hair | |
JP7275103B2 (en) | Novel cosmetic use of Nephelium lapaceum extract | |
JP6387219B2 (en) | Skin external preparation composition containing tangeretin and EGCG | |
CN105902402A (en) | Active mixture | |
JP6921440B2 (en) | Composition for promoting melanin production containing thistle extract as an active ingredient | |
BR112014031168B1 (en) | NON-THERAPEUTIC METHOD FOR STIMULATION OF HYALURONAN BIOSYNTHESIS, PHARMACEUTICAL OR DERMATOLOGICAL COMPOSITION, AND USE OF THE SAME | |
JP2011519887A (en) | Cosmetics containing cistus herb extract | |
CN107412031B (en) | Skin external composition containing hesperetin | |
JP2001163754A (en) | Anti-aging agent and cosmetic formulated therewith | |
JP4101106B2 (en) | Moisturizing plant extract and external preparation, cosmetic, bath preparation and cleaning agent containing the extract | |
EP2322138A2 (en) | Antimicrobial composition | |
JP5765744B2 (en) | Preventive or therapeutic agent for atopic dermatitis, and external preparation | |
JP2000143479A (en) | Skin-bleaching cosmetic | |
JP4716692B2 (en) | Anti-inflammatory skin external preparation containing loofah root extract | |
JP2005247826A (en) | Decorin production-promoting agent and skin care preparation for external use containing the same | |
JP6474227B2 (en) | Composition for toiletry products containing plant extract | |
JPH07277920A (en) | Cosmetic containing steam-distilled water and/or extract of lemongrass | |
JPH0725660B2 (en) | Cosmetics with anti-inflammatory properties against sunburn | |
JP3670183B2 (en) | Cosmetics | |
KR101322850B1 (en) | The cosmetic composition for pore-minimizing and inhibition of Sebum Secretion containing the extract of leaves of Mentha arvensis var. piperascens, wheat bud, and Platycodon grandiflorum | |
JP2008247787A (en) | External preparation for skin | |
KR20150050980A (en) | Cosmetic composition and external composition comprising Withania somnifera for anti-inflammatory | |
JP2001114664A (en) | Cosmetic | |
KR102468538B1 (en) | Skin improvement composition containing wild geranium extract with excellent antioxidant, whitening and anti-inflammatory effects | |
JPH08283122A (en) | Skin cosmetic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070720 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20101207 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110202 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20110204 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110308 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110329 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 4716692 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140408 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |